Michael Aaron Kelly is of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 52,054 shares of FOLD, which is worth approximately $499,197. The most recent transaction as insider was on Jun 06, 2024, when has been sold 11,847 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.1K
0% 3M change
29.47% 12M change
Total Value Held $499,197

Michael Aaron Kelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
11,847 Added 18.54%
52,054 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
8,584 Added 17.59%
40,207 Common Stock
Jun 09 2022
BUY
Grant, award, or other acquisition
-
12,671 Added 28.61%
31,623 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
10,115 Added 34.8%
18,952 Common Stock
Dec 01 2020
BUY
Grant, award, or other acquisition
-
8,837 Added 50.0%
8,837 Common Stock

Also insider at

NEO
NEOGENOMICS INC Healthcare
BOOM
DMC Global Inc. Energy
HOOK
HOOKIPA Pharma Inc. Healthcare
APRE
Aprea Therapeutics, Inc. Healthcare
PRME
Prime Medicine, Inc.
MAK

Michael Aaron Kelly

Philadelphia, PA

Track Institutional and Insider Activities on FOLD

Follow AMICUS THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD